News · Approval
1,551 stories
Sep 28, 26Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor
Sep 28, 26Mirum posts phase 3 hepatitis win for ‘commercially differentiated’ challenger to Gilead, Vir
Sep 25, 26STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic